Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Commonly employed in research for creating analogs in drug discovery programs targeting inflammatory diseases and neurological disorders. Also utilized in agrochemicals for designing bioactive molecules with improved metabolic stability due to the trifluoromethyl group.